Unknown

Dataset Information

0

Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in Scn5a1798insD/+ mice.


ABSTRACT: AIMS:SCN5A mutations are associated with arrhythmia syndromes, including Brugada syndrome, long QT syndrome type 3 (LQT3), and cardiac conduction disease. Long QT syndrome type 3 patients display atrio-ventricular (AV) conduction slowing which may contribute to arrhythmogenesis. We here investigated the as yet unknown underlying mechanisms. METHODS AND RESULTS:We assessed electrophysiological and molecular alterations underlying AV-conduction abnormalities in mice carrying the Scn5a1798insD/+ mutation. Langendorff-perfused Scn5a1798insD/+ hearts showed prolonged AV-conduction compared to wild type (WT) without changes in atrial and His-ventricular (HV) conduction. The late sodium current (INa,L) inhibitor ranolazine (RAN) normalized AV-conduction in Scn5a1798insD/+ mice, likely by preventing the mutation-induced increase in intracellular sodium ([Na+]i) and calcium ([Ca2+]i) concentrations. Indeed, further enhancement of [Na+]i and [Ca2+]i by the Na+/K+-ATPase inhibitor ouabain caused excessive increase in AV-conduction time in Scn5a1798insD/+ hearts. Scn5a1798insD/+ mice from the 129P2 strain displayed more severe AV-conduction abnormalities than FVB/N-Scn5a1798insD/+ mice, in line with their larger mutation-induced INa,L. Transverse aortic constriction (TAC) caused excessive prolongation of AV-conduction in FVB/N-Scn5a1798insD/+ mice (while HV-intervals remained unchanged), which was prevented by chronic RAN treatment. Scn5a1798insD/+-TAC hearts showed decreased mRNA levels of conduction genes in the AV-nodal region, but no structural changes in the AV-node or His bundle. In Scn5a1798insD/+-TAC mice deficient for the transcription factor Nfatc2 (effector of the calcium-calcineurin pathway), AV-conduction and conduction gene expression were restored to WT levels. CONCLUSIONS:Our findings indicate a detrimental role for enhanced INa,L and consequent calcium dysregulation on AV-conduction in Scn5a1798insD/+ mice, providing evidence for a functional mechanism underlying AV-conduction disturbances secondary to gain-of-function SCN5A mutations.

SUBMITTER: Rivaud MR 

PROVIDER: S-EPMC7544532 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in Scn5a1798insD/+ mice.

Rivaud Mathilde R MR   Marchal Gerard A GA   Wolswinkel Rianne R   Jansen John A JA   van der Made Ingeborg I   Beekman Leander L   Ruiz-Villalba Adrián A   Baartscheer Antonius A   Rajamani Sridharan S   Belardinelli Luiz L   van Veen Toon A B TAB   Basso Cristina C   Thiene Gaetano G   Creemers Esther E EE   Bezzina Connie R CR   Remme Carol Ann CA  

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20201001 10


<h4>Aims</h4>SCN5A mutations are associated with arrhythmia syndromes, including Brugada syndrome, long QT syndrome type 3 (LQT3), and cardiac conduction disease. Long QT syndrome type 3 patients display atrio-ventricular (AV) conduction slowing which may contribute to arrhythmogenesis. We here investigated the as yet unknown underlying mechanisms.<h4>Methods and results</h4>We assessed electrophysiological and molecular alterations underlying AV-conduction abnormalities in mice carrying the Scn  ...[more]

Similar Datasets

| S-EPMC6720130 | biostudies-literature
| S-EPMC7757849 | biostudies-literature
| S-EPMC6655535 | biostudies-literature
| S-EPMC5430524 | biostudies-literature
| S-EPMC4545406 | biostudies-literature
| S-EPMC7056561 | biostudies-literature
| S-EPMC4344130 | biostudies-literature
| S-EPMC3963462 | biostudies-literature
| S-EPMC6595470 | biostudies-literature
| S-EPMC5608194 | biostudies-literature